CureVac’s COVID-19 vaccine shows protection against South Africa variant in preclinical study

CureVac’s COVID-19 vaccine shows protection against South Africa variant in preclinical study

Submitted by admin on March 23, 2021 - 11:18pm
Source: 
Biopharma Reporter
News Tags: 
CureVac
COVID-19
vaccines
B.1.351 variant
COVID-19 variants
Headline: 
CureVac’s COVID-19 vaccine shows protection against South Africa variant in preclinical study
snippet: 

Preclinical data shows that CureVac’s COVID-19 vaccine protects against challenge infections with the B.1.351 ‘South Africa’ variant in a transgenic mouse model.

Do Not Allow Advertisers to Use My Personal information